IL18 and myeloid sarcoma: Significantly higher mRNA levels of IL-18 were constitutively expressed in PBMC of MS patients with respect to HD subjects; IL-12/IL-23p40 and TNFα, although not significantly so, were higher in RR-MS than in HD (Figure 4D–F).